ARCHIVES

Foundation sees Grants Applications On Chronic Conditions

This article is from The Cancer Letter archive.

Vol. 22 No. 07 | February 16, 1996

Download PDF Visit The Full Archive

Related Articles

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000

ACCR Considers Foriend Membership, Meeting With ASCO

June 14, 1991

Funding opportunities listed.

June 11, 2004